{"id":"W131397720","doi":"10.3833/pdr.v2011i5.1473","title":"Mundipharma Gains Commercialisation Rights to Allos Therapeutics’ Folotyn® Outside of North America","year":2011,"lang":"en","type":"article","venue":"PharmaDeals Review","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Business","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001654032,0.0004662272,0.0003862891,0.0007936595,0.0008306077,0.001328372,0.0003869409,0.002161229,0.09689659],"category_scores_gemma":[0.001942438,0.0002218568,0.0004956229,0.0005744928,0.0006051756,0.001461825,0.0008080305,0.001384685,0.02050132],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001255632,"about_ca_system_score_gemma":0.00375134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004392122,"about_ca_topic_score_gemma":0.007614599,"domain_scores_codex":[0.9988667,0.0001440941,0.00006069465,0.0001411869,0.000646494,0.0001408869],"domain_scores_gemma":[0.9985608,0.0003518925,0.0001801835,0.00008863005,0.0004819341,0.0003364381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007164581,0.0002657504,0.001039307,0.00108507,0.00002843492,0.001425951,0.0003197742,0.0001117426,0.03154284,0.02873776,0.2962039,0.6385229],"study_design_scores_gemma":[0.00006243974,0.0002047092,0.001162147,0.0001638501,0.00001084073,0.000837556,0.00004455167,0.00004723129,0.003163948,0.0004229859,0.9938725,0.000007235813],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.009744058,0.07652071,0.001979284,0.01843196,0.002474131,0.0002979362,0.0008507904,0.0003910136,0.8893101],"genre_scores_gemma":[0.09663953,0.0444077,0.005419466,0.007118955,0.001763259,0.0002258042,0.001679595,0.0001813293,0.8425643],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.09689659,"threshold_uncertainty_score":0.3241514,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2517164448078097,"score_gpt":0.4365977792055006,"score_spread":0.1848813343976909,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}